Kleo Pharmaceuticals Enters into Research Collaboration with Green Cross LabCell (GCLC) To …
Published by on
Kleo’s ARM technology platform can rapidly develop fully synthetic bifunctional molecules that redirect a patient’s own antibodies for therapeutic effect. In …